Result Summary for 104020
| Protocol ID: | 104020 |
| Clinical Study ID: | 104020 |
| Official Title: | Blinded, randomised study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ live attenuated measles-mumps-rubella-varicella candidate vaccine when given to healthy children in their second year of life |
| Phase: | phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | Combined Measles, Mumps, Rubella, Varicella Vaccine |
| Trade/Product Name: | Priorix-Tetra |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
